Abstract | BACKGROUND: CASE REPORT: CONCLUSION: Further studies are required to elucidate the association between anti-EGFR antibodies and ILD.
|
Authors | Takeshi Yamada, Toshikazu Moriwaki, Kenji Matsuda, Yoshiyuki Yamamoto, Akinori Sugaya, Daisuke Akutsu, Tetsuya Murashita, Shinji Endo, Ichinosuke Hyodo |
Journal | Onkologie
(Onkologie)
Vol. 36
Issue 4
Pg. 209-12
( 2013)
ISSN: 1423-0240 [Electronic] Switzerland |
PMID | 23548971
(Publication Type: Case Reports, Journal Article)
|
Copyright | Copyright © 2013 S. Karger AG, Basel. |
Chemical References |
- Antibodies, Monoclonal
- Antineoplastic Agents
- Panitumumab
|
Topics |
- Antibodies, Monoclonal
(adverse effects, therapeutic use)
- Antineoplastic Agents
(adverse effects, therapeutic use)
- Colorectal Neoplasms
(drug therapy, secondary)
- Humans
- Lung Diseases, Interstitial
(chemically induced, diagnosis, prevention & control)
- Male
- Middle Aged
- Panitumumab
- Treatment Failure
- Treatment Outcome
|